Despite China’s growing demand for cosmetics with diversified functions, the country currently lacks an efficient system to deal with adverse reactions arising from the numerous new cosmetic products introduced every year. According to research by Chenxing, inspection staff from a local FDA in Shandong Province, China’s future reform of adverse reaction monitoring system will focus on four key areas.